Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 16/20 | 0.70 |
| ▸ | CHRM1 known ✓ | P11229 | 6/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL145004 | 0.83 | CHRM3 (1.00) | CHRM3CHRM2CHRM1 | |
| Iodide SCHEMBL145003 | 0.83 | CHRM3 (1.00) | CHRM3CHRM2CHRM1 | |
| SCHEMBL23777916 | 0.81 | CHRM3 (0.97) | CHRM3CHRM2CHRM1 | |
| SCHEMBL13718090 | 0.81 | CHRM3 (0.97) | CHRM3CHRM2CHRM1 | |
| Iodide SCHEMBL1394547 | 0.77 | CHRM3 (0.64) | CHRM3CHRM2CHRM1 | |
| Bromide SCHEMBL4646138 | 0.74 | CHRM3 (0.68) | CHRM3CHRM2CHRM1 | |
| Bromide SCHEMBL4646430 | 0.73 | CHRM3 (0.46) | CHRM3CHRM2CHRM1APOBEC3AAPOBEC3G | |
| SCHEMBL11747069 | 0.67 | CHRM3 (0.55) | CHRM3CHRM2CHRM1KCNH2KDM4E | |
| SCHEMBL140766 | 0.66 | CHRM3 (1.00) | CHRM3CHRM2CHRM1 | |
| SCHEMBL140765 | 0.66 | CHRM3 (1.00) | CHRM3CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120006322-A1 | DRUG DISPENSER | GLAXO GROUP LIMITED | 2012-01-12 | — | — | US | disclosed |
| EP-2257325-A1 | ACTUATION COUNTER | Glaxo Group Limited (GB) | 2010-12-08 | — | — | EP | disclosed |
| WO-2009103711-A1 | ACTUATION COUNTER | GLAXO GROUP LIMITED (GB) | 2009-08-27 | — | — | WO | disclosed |
| EP-2056908-A2 | DRUG DISPENSER | Glaxo Group Limited (GB) | 2009-05-13 | — | — | EP | disclosed |
| EP-1963307-A1 | 3- (4- { [4-(4-{ [3-(3, 3-DIMETHYL-1-PIPERIDINYL) PROPYL[0XY] PHENYL) -1-PIPERIDINYL CARBONYL }-1-NAPHTHALENYL) PROPANOIC OR PROPENOIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC DISORDERS | GLAXO GROUP LIMITED (GB) | 2008-09-03 | — | — | EP | disclosed |
| EP-1906964-A1 | PIPERAZINONE DERIVATIVES USEFUL AS HISTAMINE H3 RECEPTOR ANTAGONISTS AND/OR INVERSE AGONISTS | GLAXO GROUP LIMITED (GB) | 2008-04-09 | — | — | EP | disclosed |
| WO-2008023017-A2 | DRUG DISPENSER | GLAXO GROUP LIMITED (GB) | 2008-02-28 | — | — | WO | disclosed |
| WO-2008000777-A2 | PHENYL- PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007071691-A1 | 3- (4-{ [4-(4-{ [3-(3, 3-DIMETHYL-1-PIPERIDINYL) PROPYL] 0XY} PHENYL) -1-PIPERIDINYL] CARBONYL }-1-NAPHTHALENYL) PROPANOIC OR PROPENOIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC DISORDERS | GLAXO GROUP LIMITED (GB) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007009741-A1 | PIPERAZINONE DERIVATIVES USEFUL AS HISTAMINE H3 RECEPTOR ANTAGONISTS AND/OR INVERSE AGONISTS | GLAXO GROUP LIMITED (GB) | 2007-01-25 | — | — | WO | disclosed |